The company was researching rare dermatological diseases with no approved treatments, according to its website.
Timber and its subsidiary BioPharmX, a specialty dermatology pharmaceutical company, are now in a “stalking horse” agreement with LEO Pharma, which signed a deal in August to acquire Timber for about $14 million. The stalking horse asset purchase agreement allows LEO Pharma to sell Timber for the acquisition price.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
